Bergmann Anthony Insider Trading Activity

Average Profitability
29.4%
Insider Buys Quantity
1
Insider Buys Sum
$9,744.00
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Bergmann Anthony

According to the SEC Form 4 filings, Bergmann Anthony, being in a position of

  1. CHIEF FINANCIAL OFFICER at Capricor Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 74500 shares for $2.29M,
    over all time since 2016-03-16, has bought 4060 shares for $9,744, and sold 74500 shares for $2.29M.

Biography of Bergmann Anthony

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $2,289,8514100

Comparison of Insiders on Amount of Buys and Sells

2026-06-25SaleCapricor Therapeutics, Inc.
CAPR
CHIEF FINANCIAL OFFICER
24,100
0.0527%
$30.38$732,158-72.48%
2026-06-24SaleCapricor Therapeutics, Inc.
CAPR
CHIEF FINANCIAL OFFICER
400
0.0009%
$30.00$12,000-71.64%
2026-05-01SaleCapricor Therapeutics, Inc.
CAPR
CHIEF FINANCIAL OFFICER
25,000
0.0561%
$31.70$792,540-69.52%
2026-03-31SaleCapricor Therapeutics, Inc.
CAPR
CHIEF FINANCIAL OFFICER
25,000
0.0542%
$30.13$753,153-35.2%
2016-03-16PurchaseCapricor Therapeutics, Inc.
CAPR
Vice President of Finance
4,060
0.0236%
$2.40$9,744+29.4%
Total: 5
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.